CRISPR Therapeutics competitorsClear all

Sarepta Therapeutics's top competitors include Hemera Biosciences, Ionis Pharmaceuticals and Ultragenyx Pharmaceutical.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
Hemera Biosciences
Hemera Biosciences
Hemera Biosciences is a company that uses gene therapy as a one-time treatment in patients with age-related macular degeneration (AMD).
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Founding Date
Founding Date
1980
Founding Date
2010
Founding Date
1989
Founding Date
2010
Type
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Boulogne Billancourt, FR
Berlin, DE
Dublin, IE
Milano, IT
Chiyoda City, JP
see more
Locations
Waltham, US HQ
Locations
Carlsbad, US HQ
Locations
Novato, US HQ
Employees
Employees
74349% increase
Employees
2
Employees
7577% decrease
Employees
74021% increase
Valuation ($)
Valuation ($)
6.4 b
Valuation ($)
N/A
Valuation ($)
5.1 b
Valuation ($)
6.4 b
Twitter followers
Twitter followers
3.7 k
Twitter followers
245
Twitter followers
3.5 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
19
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
29.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
6.5
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
181719
Alexa Website Rank
N/A
Alexa Website Rank
280538
Alexa Website Rank
260258
Employee Rating
Employee Rating
3.5
Employee Rating
N/A
Employee Rating
3.7
Employee Rating
4.3

Financial

Revenue (est.)
Revenue (est.)
$540.1m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$729.3m (FY, 2020)
Revenue (est.)
$271m (FY, 2020)
Net income
Net income
($554.1m) (FY, 2020)
Net income
N/A
Net income
($486.8m) (FY, 2020)
Net income
($186.6m) (FY, 2020)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 1.3m
Total funding raised
N/A
Total funding raised
$ 200.1m
For sources of this data, please see the company profile

View company profiles

Hemera Biosciences
HQ
Waltham, US
Employees
2

Hemera Biosciences is a company that uses gene therapy as a one-time treatment in patients with age-related macular degeneration (AMD).

View company
Ionis Pharmaceuticals
HQ
Carlsbad, US
Employees
757↓ 7% decrease

Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.

View company
Ultragenyx Pharmaceutical
HQ
Novato, US
Employees
740↑ 21% increase

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

View company